Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genomics 244

Genomics Genome Medicine Gene Therapy 244

XTalks

MARCH 11, 2025

Advances in mRNA quantification are paving the way for improved vaccine analytics a critical component as the industry shifts toward multivalent mRNA vaccines. These vaccines can be engineered to address antigenic variability and stimulate a wide-ranging immune response.

Vaccination 64

Vaccination Vaccine Development Manufacturing 64

XTalks

JANUARY 6, 2025

Biomanufacturing and Automation The production of vaccines, drugs and diagnostic reagents increasingly depends on good manufacturing practice (GMP) facilities for the manufacturing of critical reagents, a reliance that has intensified since the pandemic. percent from 2021 to 2031, reaching an estimated value of $85.2

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111